Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Acquired_by_Mylan_in_2007
|
| gptkbp:affiliation |
gptkb:Federation_of_Indian_Chambers_of_Commerce_&_Industry_(FICCI)
Confederation_of_Indian_Industry_(CII) Pharmaceutical_Research_and_Manufacturers_of_America_(PhRMA) Indian_Pharmaceutical_Alliance_(IPA) |
| gptkbp:awards |
Various industry awards
|
| gptkbp:CEO |
gptkb:Rakesh_K._Sethi
|
| gptkbp:certifications |
ISO_certified
|
| gptkbp:clinicalTrials |
Conducts clinical trials
|
| gptkbp:community_involvement |
Health awareness programs
|
| gptkbp:employees |
Over 1,000
|
| gptkbp:exportedTo |
To over 30 countries
|
| gptkbp:focus_area |
Oncology
Pain management Respiratory diseases Supply chain management Infectious diseases Pediatric care Personalized medicine Vaccines Chronic diseases Biologics Nutraceuticals Artificial intelligence in healthcare Biosimilars Women’s health Telemedicine solutions Geriatric care Lifestyle diseases Blockchain in pharmaceuticals Digital_health_solutions Orphan_drugs |
| gptkbp:founded |
1995
|
| gptkbp:founder |
gptkb:B._K._Sethi
|
| gptkbp:headquarters |
New Delhi, India
|
| https://www.w3.org/2000/01/rdf-schema#label |
Baxy Pharmaceuticals
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:market |
gptkb:India
|
| gptkbp:partnerships |
Various global pharmaceutical companies
|
| gptkbp:productionCompany |
Multiple_in_India
|
| gptkbp:productLine |
Over 200 products
|
| gptkbp:products |
Generic_Drugs
|
| gptkbp:regulatoryCompliance |
FDA_approved
|
| gptkbp:researchAndDevelopment |
Yes
|
| gptkbp:revenue |
$200 million (approx.)
|
| gptkbp:specialization |
Gastroenterology
Neurology Cardiovascular Drugs Diabetes Care Anti-infectives |
| gptkbp:subsidiary |
gptkb:Mylan_N.V.
|
| gptkbp:sustainability_initiatives |
Environmental sustainability programs
|
| gptkbp:website |
www.baxy.com
|